Octave Announces Publication of Analytical Validation Study Results in Nature Communications More

About

On a mission to power the art of medicine with scientific insights to change the paradigm of care in MS

Every MS patient is unique. Knowing when and how to best treat them is the greatest challenge to solve.

At Octave, we deliver comprehensive insights that bring scientific clarity to MS, enabling an optimal care journey for patients to live more harmonious lives.

Every MS patient is unique. Knowing when and how to best treat them is the greatest challenge to solve.

At Octave, we deliver comprehensive insights that bring scientific clarity to MS, enabling an optimal care journey for patients to live more harmonious lives.

Our principles reflect our purpose.

Inquisitive Empathy

We care deeply about the patient experience—and are always open to hearing how we can improve it.

Scientific Innovation

In combination with science, we build solutions using technology, AI, and machine learning that power the art of medicine for MS providers.

Comprehensive Insights

We use rigorous scientific discipline to generate novel data and insights that address unmet needs in MS care.

Continuous Learning

The journey never ends. Based on new discoveries, we have built a foundation that allows us to learn and apply our knowledge together.

Our Leadership Team

A visionary and experienced team focused on the mission to provide precision care for MS patients.

Doug Biehn

President, Chief Executive Officer
Loading...

Jeron Evans

Chief Revenue Officer
Loading...

Mike Edgeworth, MD

Chief Population Health Officer
Loading...

Debbie Ledet

Chief Access Officer
Loading...

Stephanie McGrory

Senior Vice President, Business Development & Partnerships
Loading...

Ferhan Qureshi

Senior Vice President, Biomarker R&D
Loading...

Board of Directors

Octave is backed by seasoned and passionate healthcare leaders.

William Hagstrom

Chairman of the Board
Loading...

Brook Byers

Kleiner Perkins Caufield & Byers
Loading...

Tom Hawes

Managing Director, Healthcare, Sandbox Industries
Loading...

Grant Heidrich III

Independent Venture Capital & Private Equity Professional
Loading...

Lucy Coassin

Northpond Ventures
Loading...

Michael Pellini

Foundation Medicine, Section 32
Loading...

George Scangos

Former CEO Vir, Biogen, Exelixis
Loading...

Our Investors